North CarolinaMental Health and Substance Abuse Quality Measures Compared to Achievable Benchmarks

The NHQDR quality measures specific to Mental Health and Substance Abuse are compared to achievable benchmarks, which are derived from the top-performing States. Better performance of a State can mean higher or lower values of a measure, depending on the desired outcome. For example, low values are desirable for measures such as infant mortality, whereas high values are desirable for measures such as preventative screening. The categories of achievement have been standardized across the measure definitions so that:

 
Far away from benchmark - a State's value for a measure has not achieved 50% of the benchmark.
 
Close to benchmark - a State's value for a measure is between 50% and 90% of a benchmark (i.e., worse than the benchmark but has achieved at least half of the benchmark but not as much as 90% of a benchmark).
 
Achieved benchmark or better - a State's value for a measure is no worse than 90% of the benchmark value, the measure has achieved the benchmark. This category also includes the case in which the measure’s value is equal to or better than the benchmark.
Measures That Are Close to Benchmark
Measure Estimate Benchmark Distance to Benchmark
People age 12 and over treated for substance abuse who completed treatment course 41.1 65.2 37.0%
Measures That Are Far From Benchmark
Measure Estimate Benchmark Distance to Benchmark
Suicide deaths among persons age 12 and over per 100,000 population 15.7 9.4 67.4%
Long-stay nursing home residents have depressive symptoms 2.2 1.1 90.4%
Drug overdose deaths involving natural and semisynthetic opioids per 100,000 resident population 5.6 1.9 197.9%
Hospital inpatient stays involving opioid-related diagnoses per 100,000 population 320.1 102.9 211.2%
Emergency department visits involving opioid-related diagnoses per 100,000 population 261.3 65.2 300.5%
Drug overdose deaths involving any opioid per 100,000 resident population 19.8 4.0 390.1%
Drug overdose deaths involving other synthetic opioids (other than methadone) per 100,000 resident population 13.2 0.7 1708.2%